SCHEMBL6159344

SCHEMBL6159344

CCOC(=O)c1ccc(Oc2ccc(CN3CC(S)CC3=O)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.44
MMP13 P45452 1/20 0.42
TSHR P16473 2/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
LMNA P02545 1/20 0.40
HTT P42858 3/20 0.40
GAA P10253 2/20 0.40
CYP2C19 P33261 2/20 0.40
KDM4E B2RXH2 1/20 0.40
CYP2C9 P11712 1/20 0.40
RECQL P46063 1/20 0.40
MAPK10 P53779 1/20 0.40
CYP3A4 P08684 1/20 0.39
NPBWR1 P48145 1/20 0.39
MCHR1 Q99705 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6157284 0.85 GRM2 (0.51) ALDH1A1L3MBTL1MEN1KMT2ASMN1; SMN2
SCHEMBL6158864 0.84 PARP10 (0.46) ALDH1A1KMT2ASMN1; SMN2HTT
SCHEMBL6158771 0.83 SMN1; SMN2 (0.54) ALDH1A1L3MBTL1SMN1; SMN2TSHRHPGD
SCHEMBL6156978 0.83 ALDH1A1 (0.46) ALDH1A1L3MBTL1MEN1KMT2ASMN1; SMN2
SCHEMBL6158478 0.81 HPGD (0.43) ALDH1A1L3MBTL1MEN1KMT2ASMN1; SMN2
SCHEMBL6158922 0.80 S1PR5 (0.49) ALDH1A1L3MBTL1KMT2ASMN1; SMN2MMP13
SCHEMBL6158929 0.80 S1PR5 (0.49) ALDH1A1L3MBTL1KMT2ASMN1; SMN2MMP13
SCHEMBL6158376 0.80 HPGD (0.54) MEN1KMT2ASMN1; SMN2TSHRHPGD
SCHEMBL6158698 0.80 HPGD (0.54) MEN1KMT2ASMN1; SMN2TSHRHPGD
SCHEMBL6157242 0.79 ALDH1A1 (0.56) ALDH1A1L3MBTL1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953789-B2 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-10-11 US disclosed
US-20040157894-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
US-6699881-B2 MATRIX METALLOPROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
US-20030078253-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2003-04-24 US disclosed
US-6420415-B1 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-16 US disclosed
EP-1132379-A1 NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078253-A1 Thiol compounds, their production and use TST, QSOX1, SULT1E1 ALDH1A1 905/4885L3MBTL1 3315/4885MEN1 3957/4885
US-20040157894-A1 Thiol compounds, their production and use TST, SULT1E1, QSOX1 ALDH1A1 877/4885L3MBTL1 3278/4885MEN1 3906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.